UPDATED Apr 16, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A211050 | ₩4,900.00 | 9.1% | 135.6% | ₩241.6b | ₩3,800.00 | PE8.2x | E41.8% | 1.4% | Insurance | ||
A439090 | ₩18,670.00 | -0.8% | n/a | ₩305.8b | n/a | PE26.3x | E49.6% | n/a | Household | ||
A080160 | ₩15,450.00 | -1.2% | -11.5% | ₩272.7b | ₩16,000.00 | PE59.7x | E67.7% | 1.6% | Consumer Services | ||
YGG | ฿7.90 | 6.0% | 6.8% | ฿4.8b | ฿10.75 | PE68.5x | E35.2% | 3.4% | Media | ||
A254490 | ₩19,590.00 | -2.3% | -32.1% | ₩282.8b | n/a | PE55.9x | E75.7% | n/a | Tech | ||
A204620 | ₩6,680.00 | 4.2% | 56.3% | ₩379.3b | ₩10,333.33 | PS4.1x | E63.0% | n/a | Commercial Services | ||
A108860 | ₩16,450.00 | -3.5% | -20.5% | ₩442.7b | n/a | PS8.4x | E98.9% | n/a | Software | ||
OSE | €4.62 | -2.1% | -7.6% | €99.5m | €7.15 | PS44.7x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
CALTX | kr101.00 | -12.6% | -20.3% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
RDUE | €9.85 | 4.8% | 1.1% | €61.6m | €11.70 | n/a | E42.0% | n/a | Capital Goods | ||
GWIND | ₺25.56 | 0.4% | 55.1% | ₺14.1b | ₺39.79 | PE22.1x | E60.9% | 1.8% | Utilities | ||
WAYS | kr23.65 | -1.5% | -48.6% | kr190.8m | kr39.75 | PS1.7x | E81.8% | 0% | Tech | ||
GIG | kr34.70 | 2.7% | 31.2% | kr4.5b | kr49.20 | PE28.6x | E39.9% | n/a | Consumer Services | ||
ELABS | kr14.10 | -0.8% | 3.4% | kr1.5b | kr25.00 | PS21.6x | E124.6% | n/a | Software | ||
NOHAL | kr22.40 | 1.8% | -1.8% | kr876.0m | kr32.50 | PS8.6x | E56.0% | n/a | Food, Beverage & Tobacco | ||
MVW | kr8.20 | -4.1% | -1.2% | kr239.4m | kr12.20 | PS21.8x | E66.0% | n/a | Materials | ||
ZVRA | US$4.77 | 0.8% | -22.3% | US$200.3m | US$19.00 | PS7.3x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$9.70 | -35.2% | -35.2% | US$244.1m | US$26.90 | PS5x | E64.5% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$4.08 | -16.4% | 45.7% | US$225.0m | US$8.50 | PS2.6x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.77 | -3.1% | 105.0% | €129.5m | €12.75 | PE27.3x | E22.8% | n/a | Capital Goods | ||
NVG | zł2.42 | -4.3% | 69.2% | zł84.7m | zł3.71 | PE8.7x | E28.5% | n/a | Diversified Financials | ||
NEWBRY | kr3.43 | -1.7% | -40.9% | kr83.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
FDE | €33.30 | -1.8% | -12.4% | €174.2m | €64.07 | PE22.2x | E32.3% | n/a | Energy | ||
KEBNI B | kr1.58 | -0.9% | 46.0% | kr428.4m | kr1.80 | PS6x | E96.2% | n/a | Tech |